William Audeh
Chief Medical Officer at Agendia | Oceanside, California, United States
William Audeh’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Stanford University, Fellowship, November 1986 to November 1989
Stanford University, Chief Resident, November 1985 to November 1986
Stanford University, Internship/Residency, November 1982 to November 1985
Agendia is a precision oncology company headquartered in Irvine, California, committed to bringing patients with early stage breast cancer and their physicians the information they need to make the best decisions for the full treatment journey. The company currently offers two commercially-available genomic profiling tests, supported by the highest levels of clinical and real world evidence, that provide comprehensive genomic information that can be used to identify the most effective breast cancer treatment possible for each patient. MammaPrint®, the 70-gene breast cancer recurrence assay, is the only FDA-cleared risk of recurrence test backed by peer-reviewed, prospective outcome data and inclusion in both national and international treatment guidelines. BluePrint®, the 80-gene molecular subtyping assay, is the only commercially-available test that evaluates the underlying biology of a tumor to determine what is driving its growth. Together, MammaPrint® and BluePrint® provide a comprehensive genomic profile to help physicians make more informed decisions in the pre- and post-operative treatment settings. Agendia develops evidence-based novel genomic tests and forges partnerships with groundbreaking companies to develop next-generation digital treatment tools. The ongoing research builds an arsenal of data that improve patient outcomes and support the evolving clinical needs of patients with breast cancer and their physicians every step of the way, from initial diagnosis to cancer-free. Agendia’s assays can be ordered on core biopsies or surgical specimens to inform pre- and post-operative treatment decisions. For more information on Agendia’s assays and ongoing trials, please visit www.agendia.com. For view our social media policies, please visit https://agendia.com/legal-compliance/
Discover more about AgendiaBreast Cancer Genomics 🧬 Agendia | Medical Publication Writer | CMPP
Medical Publications Writer at Agendia
(November 2023 – Present)
Senior Molecular Oncology Specialist 🧬
Senior Molecular Oncology Specialist at Agendia
(Oct 2025 – Present)
Director at Agendia, Inc.
Director, Capital Markets & Investments at Agendia
(Jan 2024 – Present)
Senior Molecular Oncology Specialist - North Texas - Agendia
Senior Molecular Oncology Specialist at Agendia
(Sep 2020 – Present)
Field Leadership | Regional Sales Director at Agendia
Regional Sales Director at Agendia
(Nov 2025 – Present)
Principal Scientist | Bioinformatics | Clinical Data Science | Oncology | Real-World Evidence
- Lead clinical and bioinformatics projects integrating transcriptomic and real-world evidence (RWE) data to inform precision oncology research
- Support data interpretation, and manuscript development in collaboration with KOLs and Medical Affairs
- Implement automation workf...
What is William Audeh phone number?
William Audeh phone number is 3109179241 and 3108490561.
How to contact William Audeh?
If you want to call William Audeh try calling on 3109179241 and 3108490561. (updated on September 29, 2025)
What company does William Audeh work for?
William Audeh works for Agendia.
What is William Audeh's role at Agendia?
William Audeh is Chief Medical Officer
What industry does William Audeh work in?
William Audeh works in the Hospital & Health Care industry.